Aurora Spine Corporation (ASG.V)
CAD 0.43
(1.18%)
CAD 0.43
(1.18%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -1.68 Million USD | -11.93% |
| 2022 | -1.5 Million USD | 36.36% |
| 2021 | -2.35 Million USD | -916.58% |
| 2020 | -232.08 Thousand USD | 81.5% |
| 2019 | -1.25 Million USD | -1739.16% |
| 2018 | -68.19 Thousand USD | 96.96% |
| 2017 | -2.24 Million USD | -33.41% |
| 2016 | -1.67 Million USD | 42.42% |
| 2015 | -2.91 Million USD | 61.16% |
| 2014 | -7.5 Million USD | 0.0% |
| 2012 | -1.44 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -266.92 Thousand USD | 6.54% |
| 2024 Q2 | -154.1 Thousand USD | 42.27% |
| 2024 Q3 | 71.12 Thousand USD | 146.15% |
| 2023 Q2 | -482.41 Thousand USD | 27.23% |
| 2023 Q4 | -285.59 Thousand USD | -14.41% |
| 2023 Q3 | -249.61 Thousand USD | 48.26% |
| 2023 FY | -1.68 Million USD | -11.93% |
| 2023 Q1 | -662.93 Thousand USD | 21.04% |
| 2022 Q2 | -159.66 Thousand USD | 58.7% |
| 2022 Q1 | -386.57 Thousand USD | 57.24% |
| 2022 Q4 | -839.56 Thousand USD | -625.94% |
| 2022 FY | -1.5 Million USD | 36.36% |
| 2022 Q3 | -115.65 Thousand USD | 27.57% |
| 2021 FY | -2.35 Million USD | -916.58% |
| 2021 Q1 | -386.74 Thousand USD | -816.89% |
| 2021 Q3 | -368.21 Thousand USD | 47.43% |
| 2021 Q4 | -903.96 Thousand USD | -145.5% |
| 2021 Q2 | -700.4 Thousand USD | -81.1% |
| 2020 Q2 | 34.47 Thousand USD | 106.15% |
| 2020 Q4 | -42.18 Thousand USD | -112.55% |
| 2020 FY | -232.08 Thousand USD | 81.5% |
| 2020 Q3 | 336.16 Thousand USD | 875.09% |
| 2020 Q1 | -560.54 Thousand USD | 4.53% |
| 2019 Q2 | -44.1 Thousand USD | 78.55% |
| 2019 FY | -1.25 Million USD | -1739.16% |
| 2019 Q4 | -587.16 Thousand USD | -40.67% |
| 2019 Q3 | -417.39 Thousand USD | -846.38% |
| 2019 Q1 | -205.6 Thousand USD | -130.25% |
| 2018 Q4 | -89.29 Thousand USD | -163.9% |
| 2018 FY | -68.19 Thousand USD | 96.96% |
| 2018 Q1 | -159.68 Thousand USD | 82.22% |
| 2018 Q2 | 41.04 Thousand USD | 125.7% |
| 2018 Q3 | 139.73 Thousand USD | 240.44% |
| 2017 Q1 | -557.76 Thousand USD | 19.66% |
| 2017 FY | -2.24 Million USD | -33.41% |
| 2017 Q2 | -456.12 Thousand USD | 18.22% |
| 2017 Q4 | -898.08 Thousand USD | -173.49% |
| 2017 Q3 | -328.38 Thousand USD | 28.01% |
| 2016 Q1 | -306.21 Thousand USD | 46.92% |
| 2016 Q3 | -523 Thousand USD | -235.71% |
| 2016 Q4 | -694.23 Thousand USD | -32.74% |
| 2016 Q2 | -155.79 Thousand USD | 49.12% |
| 2016 FY | -1.67 Million USD | 42.42% |
| 2015 Q4 | -576.85 Thousand USD | 6.22% |
| 2015 Q3 | -615.12 Thousand USD | -40.05% |
| 2015 FY | -2.91 Million USD | 61.16% |
| 2015 Q2 | -439.21 Thousand USD | 65.82% |
| 2015 Q1 | -1.28 Million USD | 45.05% |
| 2014 Q1 | -1.27 Million USD | 0.0% |
| 2014 Q2 | -1.5 Million USD | -17.54% |
| 2014 Q3 | -2.38 Million USD | -59.05% |
| 2014 Q4 | -2.33 Million USD | 2.11% |
| 2014 FY | -7.5 Million USD | 0.0% |
| 2013 Q3 | -643.93 Thousand USD | 0.0% |
| 2012 FY | -1.44 Million USD | 0.0% |
| 2012 Q3 | -261.61 Thousand USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Perimeter Medical Imaging AI, Inc. | -18.94 Million CAD | 91.129% |
| Therma Bright Inc. | -3.76 Million CAD | 55.396% |
| Theralase Technologies Inc. | -4.57 Million CAD | 63.233% |
| VentriPoint Diagnostics Ltd. | -4.87 Million CAD | 65.505% |